CLEVELAND, Feb. 25, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its 2013 fourth quarter and annual financial results at approximately 4:00 PM EST on Thursday, March 13, 2014, and host a conference call shortly thereafter at 4:30 PM EST to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:
Date||March 13, 2014|
Time||4:30 p.m. (Eastern Time)|
Telephone access: US and Canada||
Telephone access: International||
Live webcast||www.athersys.com, under the Investors section|
A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM (Eastern Time)
on March 27, 2014
at the aforementioned URL, or by dialing 800-585-8367 or 855-859-2056 in the U.S. and Canada
, or from abroad 404-537-3406, and entering access code 96437720.About AthersysAthersys
is a clinical stage biotechnology
company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStemŽ cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas. The Company currently has several clinical stage programs involving MultiStem, including for treating inflammatory bowel disease, ischemic stroke, damage caused by myocardial infarction, and for the prevention of graft-versus-host disease. Athersys
has also developed a diverse portfolio that includes other technologies and product development opportunities, and has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology
companies, as well as world-renowned research institutions in the United States
to further develop its platform and products.
CONTACT: William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
Lisa M. WilsonIn-Site Communications
Tel: (917) 543-9932
Source: Athersys, Inc.